Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
1.
J Appl Microbiol ; 128(2): 584-597, 2020 Feb.
Article in English | MEDLINE | ID: mdl-31602730

ABSTRACT

AIMS: Probiotics have the ability to enhance the immune system, produce anti-inflammatory action and promote wound healing process. The first aim of the study was to isolate pathogenic micro-organisms from sites of chronic ulcerative lesion. The second aim was to evaluate probiotic efficacy of SYNBIO® (1:1 combination of Lactobacillus rhamnosus IMC 501® and Lactobacillus paracasei IMC 502® ) in counteracting wound infections. METHODS AND RESULTS: Several bacterial pathogens were isolated from chronic ulcerative lesions and identified by morphological, biochemical and molecular techniques. SYNBIO® probiotic formulation was investigated for its antimicrobial activity, minimum inhibitory concentration, co-aggregation and adherence capacity against the isolated pathogens. Moreover, SYNBIO was also tested in combination with some medical devices, using an in vitro model, in order to simulate a real ulcerative wound infection. Probiotic formulation demonstrated an inhibitory action against all the tested pathogens and their mixture (MIX), with an increased ability of co-aggregation during time. In addition, the adhesion percentage of probiotic micro-organisms to human keratinocyte (HaCaT cells) and human fibroblasts (NHF), calculated by an in vitro model, was 19% and 17% respectively, highlighting the possibility to create a protective environment preventing pathogens' biofilm formation in order to contrast infections. CONCLUSIONS: SYNBIO® probiotics showed a very good antimicrobial capacity and adhesion percentage to HaCaT cells and fibroblasts, giving the opportunity to be successfully used as complement to conventional therapies in the treatment of chronic ulcerative lesions. SIGNIFICANCE AND IMPACT OF THE STUDY: A new therapeutic approach with probiotics (supplemented in topical applications, excluding side effects) able to eliminate pathogenic micro-organisms and improve healing of chronic ulcerative lesions.


Subject(s)
Bacteria/isolation & purification , Colitis, Ulcerative/drug therapy , Probiotics/administration & dosage , Bacteria/classification , Bacteria/genetics , Bacterial Adhesion , Bacterial Physiological Phenomena , Chronic Disease/therapy , Colitis, Ulcerative/microbiology , Fibroblasts/microbiology , Humans , Keratinocytes/microbiology , Lacticaseibacillus paracasei/physiology , Lacticaseibacillus rhamnosus/physiology
2.
Eur Rev Med Pharmacol Sci ; 21(6): 1421-1431, 2017 03.
Article in English | MEDLINE | ID: mdl-28387882

ABSTRACT

OBJECTIVE: The aim of this study is to evaluate the efficacy and safety of a new ointment containing Hyaluronic Acid and collagenase from non-pathogenic Vibrio alginolyticus. PATIENTS AND METHODS: Double blind, multicenter, controlled clinical trial (no. ISRCTN71239043) conducted to demonstrate the superiority of Hyaluronic Acid-Collagenase applied once a day over placebo in mean reduction of devitalized/fibrinous/slough tissue after 15 days of treatment. 113 patients with venous ulcers were enrolled and randomized to receive active treatment therapy or vehicle preparation. Both arms also received compression therapy. Subjects were assessed at baseline and at 4 different clinical study visits up to a maximum of 30 days. Outcome measures included mean percentage debridement evaluated by digital planimetry, pain during change of dressing measured on a visual analogue scale and adverse event assessment for tolerance. RESULTS: After 15 days the debridement rate in the active group was 67.5% compared to 59% in the placebo group (p = 0.0436). A significantly higher number of patients in the treatment group achieved 100% debridement by day 15 (p = 0.0025) than in the control group, and a higher percentage also demonstrated complete debridement at every other time point. Pain perception was similar in both groups with low levels during medication. No differences in tolerance were observed between groups. CONCLUSIONS: Chronic venous ulcers treated with this novel compound of Hyaluronic Acid and collagenase resulted in a significantly higher debridement rate at Day 15 vs. the control group. Hyaluronic Acid-Collagenase was well tolerated and a low degree of pain was perceived during dressing change. The preparation of 0.2% of Hyaluronic acid-collagenase shows significant benefits in the management of chronic ulcers.


Subject(s)
Collagenases/therapeutic use , Debridement , Varicose Ulcer/drug therapy , Wound Healing , Aged , Aged, 80 and over , Double-Blind Method , Female , Humans , Male , Middle Aged , Treatment Outcome
3.
Sci Total Environ ; 580: 699-709, 2017 Feb 15.
Article in English | MEDLINE | ID: mdl-27986319

ABSTRACT

We investigated relationships among insecticides and aquatic invertebrate communities in 22 streams of two soy production regions of the Argentine Pampas over three growing seasons. Chlorpyrifos, endosulfan, cypermethrin, and lambda-cyhalothrin were the insecticides most frequently detected in stream sediments. The Species at Risk (SPEAR) pesticide bioassessment index (SPEARpesticides) was adapted and applied to evaluate relationships between sediment insecticide toxic units (TUs) and invertebrate communities associated with both benthic habitats and emergent vegetation habitats. SPEARpesticides was the only response metric that was significantly correlated with total insecticide TU values for all three averaged data sets, consistently showing a trend of decreasing values with increasing TU values (r2=0.35 to 0.42, p-value=0.001 to 0.03). Although pyrethroids were the insecticides that contributed the highest TU values, toxicity calculated based on all insecticides was better at predicting changes in invertebrate communities than toxicity of pyrethroids alone. Crustaceans, particularly the amphipod Hyalella spp., which are relatively sensitive to pesticides, played a large role in the performance of SPEARpesticides, and the relative abundance of all crustaceans also showed a significant decreasing trend with increasing insecticide TUs for two of three data sets (r2=0.30 to 0.57, p-value=0.003 to 0.04) examined. For all data sets, total insecticide TU was the most important variable in explaining variance in the SPEARpesticides index. The present study was the first application of the SPEAR index in South America, and the first one to use it to evaluate effects of pesticides on invertebrate communities associated with aquatic vegetation. Although the SPEAR index was developed in Europe, it performed well in the Argentine Pampas with only minor modifications, and would likely improve in performance as more data are obtained on traits of South American taxa, such as pesticide sensitivity and generation time.


Subject(s)
Agriculture , Insecticides/analysis , Invertebrates/drug effects , Rivers , Water Pollutants, Chemical/analysis , Animals , Environmental Monitoring , Europe , Geologic Sediments/analysis , South America , Glycine max/growth & development
4.
J Wound Care ; 25(12): 763-767, 2016 Dec 02.
Article in English | MEDLINE | ID: mdl-27974011

ABSTRACT

Gorlin-Goltz syndrome is mainly characterised by the development of numerous multicentric and relapsing cutaneous basal cell carcinomas (BCCs). A major problem for patients with Gorlin-Goltz syndrome is the large amount of BCCs that can invade the deep underlying structures, especially the face. Here, we describe the case of a 23-year-old male affected by Gorlin-Goltz syndrome. He had recurrent BCCs on a hairless scalp and dorsum since he was 17 years old and underwent four surgical procedures to excise BCCs, including a reconstruction with anteromedial thigh perforator flap. For each of the surgical procedures, a phenotypic study on peripheral blood mononuclear cells using flow cytometry was performed on the same day of surgery, and on days 7, 14 and 21 after surgery. The role of the tumour-specific cytolytic immune response as a potential future treatment of syndromic BCCs and its trend in relation to surgical ablation of large portions of tumour tissue was examined, and the cosmetic and therapeutic results are shown.


Subject(s)
Basal Cell Nevus Syndrome/immunology , Basal Cell Nevus Syndrome/surgery , Head and Neck Neoplasms/immunology , Head and Neck Neoplasms/surgery , Perforator Flap , Humans , Male , Phenotype , Thigh , Young Adult
5.
Semin Vasc Surg ; 28(3-4): 151-9, 2015.
Article in English | MEDLINE | ID: mdl-27113281

ABSTRACT

Wound healing is a systemic response to injury that impacts the entire body and not just the site of tissue damage; it represents one of the most complex biological processes. Our knowledge of wound healing continues to evolve and it is now clear that the wound microenvironment plays a crucial role. The interactions between cells and the surface microenvironment, referred to as the "biofilm," contributes to skin homeostasis and healing. Understanding the functional complexity of the wound microenvironment informs how various factors such as age, ischemia, or bacterial infections can impair or arrest the normal healing processes, and it also allows for the possibility of acting therapeutically on healing defects with microenvironment manipulation. Microbes represent a particularly important factor for influencing the wound microenvironment and therefore wound healing. Moreover, the role of infections, particularly those that are sustained by biofilm-forming bacteria, is mutually related to other microenvironment aspects, such as humidity, pH, metalloproteinases, and reactive oxygen species, on which the modern research of new therapeutic strategies is focused. Today, chronic wounds are a rapidly growing health care burden and it is progressively understood that many non-healing wounds might benefit from therapies that target microorganisms and their biofilm communities. There is no doubt that host factors like perfusion impairments, venous insufficiency, pressure issues, malnutrition, and comorbidities strongly impact the healing processes and therefore must be targeted in the therapeutic management, but this approach might be not enough. In this article, we detail how bacterial biofilms and related factors impair wound healing, the reasons they must be considered a treatment target that is as important as the host's local and systemic pathologic conditions, and the latest therapeutic strategies derived from the comprehension of the wound microenvironment.


Subject(s)
Bacteria/growth & development , Biofilms/growth & development , Skin/microbiology , Wound Healing , Wound Infection/microbiology , Animals , Bacteria/metabolism , Bacteria/pathogenicity , Bacterial Load , Cellular Microenvironment , Host-Pathogen Interactions , Humans , Hydrogen-Ion Concentration , Matrix Metalloproteinases/metabolism , Prognosis , Reactive Oxygen Species/metabolism , Skin/enzymology , Skin/pathology , Wound Infection/enzymology , Wound Infection/pathology , Wound Infection/therapy
6.
Spinal Cord ; 52 Suppl 3: S1-3, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25376307

ABSTRACT

STUDY DESIGN: Marjolin's ulcer is a squamous cell carcinoma that develops in posttraumatic scars and chronic wounds. Suspicion of such lesions should be raised in chronic wounds demonstrating characteristic changes. We have reported the peculiar phenomenon of malignant transformation of chronic pressure sores that occurred in a paraplegic patient. OBJECTIVES: The aim of this study was to cover the extensive defects by a last resort reconstructive option. SETTING: Department of Plastic and Reconstructive Surgery, Università Politecnica delle Marche, Ancona, Italy. METHODS AND RESULTS: A 40-year-old paraplegic man, with multiple hemangioblastomas of the brain and spinal cord due to Von Hippel Lindau syndrome developed pressure ulcers with unstable healing over the sacral, trochanteric, bilateral, and ischiatic areas after 15 years from neurosurgery. The biopsy result showed an invasive squamous carcinoma. Carcinomas in pressure sores are highly aggressive, and they need to be treated more radically. In our case we opted for a demolitive surgical treatment including musculocutaneous rotational flap harvested from total left thigh to cover the extensive defects. The limb was previously disarticulated. CONCLUSION: In Marjolin's ulcer, multiple biopsies are the first-line modality for the early diagnosis as they are a safe method with high rate of accuracy. First-line treatment is surgery consisting of radical excision with lymph node dissection, if they are involved. Adjuvant radiation therapy may be used in selected patients. Management of massive pelvic defects can be a challenging problem. The pedicled lower limb flap offers a technique that can be considered as a last resort procedure for extensive defects where other options are insufficient or not available anymore. In our case the patient is disease-free after 2 years of follow-up.


Subject(s)
Carcinoma, Squamous Cell/surgery , Cerebellar Neoplasms/surgery , Hemangioblastoma/surgery , Paraplegia/surgery , Plastic Surgery Procedures , Spinal Cord Neoplasms/surgery , von Hippel-Lindau Disease/surgery , Adult , Carcinoma, Squamous Cell/etiology , Cerebellar Neoplasms/etiology , Hemangioblastoma/etiology , Humans , Male , Paraplegia/etiology , Spinal Cord Neoplasms/etiology , Thigh/surgery , Treatment Outcome , Ulcer/complications , Ulcer/surgery , Wound Healing/physiology , von Hippel-Lindau Disease/complications
7.
Microsurgery ; 27(1): 43-7, 2007.
Article in English | MEDLINE | ID: mdl-17206621

ABSTRACT

Ischemia/reperfusion injury is regarded as the main cause of failure in revascularization of limbs and transfer of free flaps in the so called nonreflow phenomenon. This type of damage is caused by the production of free radicals, above all, of neutrophils that release great quantities of extracellular superoxide through the action of a membrane enzyme. In our study we used 40 white rabbits. Rabbit rectus femoris muscle is perfused by a single artery and vein and is therefore a valuable model for study of ischemia-induced reperfusion injury of skeletal muscle. The objective of this study was to individualize a valid method of protection for the muscle from damage by ischemia-induced reperfusion injury. We have tested the effectiveness of WEB2170, a PAF antagonist, of hyperbaric oxygen therapy one (HBO), and of combined employment of WEB2170 and HBO. The results show that both PAF and HBO play important protective roles against damage from ischemia/reperfusion injury, and that the combined employment of both therapies has a synergistic effect. We propose therefore a new therapeutic protocol for the prevention of damage resulting from ischemia/reperfusion injury with the simultaneous employment of this PAF and HBO.


Subject(s)
Azepines/therapeutic use , Hyperbaric Oxygenation , Platelet Aggregation Inhibitors/therapeutic use , Reperfusion Injury/prevention & control , Triazoles/therapeutic use , Animals , Combined Modality Therapy , Disease Models, Animal , Muscle, Skeletal/blood supply , Peroxidase/metabolism , Rabbits
8.
Neurol Sci ; 27(1): 58-62, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16688601

ABSTRACT

Demyelinating inflammatory diseases of central and peripheral myelin share similar aetiopathogenesis but rarely occur simultaneously in the same individual. Here we report two clinical cases of temporal association between multiple sclerosis (MS) and chronic inflammatory demyelinating polyneuropathy (CIDP). Our finding supports the hypothesis that clinically manifested central and peripheral demyelinating diseases could result from a common pathogenic event characterised by T-cell autoimmunity spreading from central to peripheral myelin.


Subject(s)
Central Nervous System/immunology , Multiple Sclerosis/complications , Multiple Sclerosis/immunology , Peripheral Nervous System/immunology , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/complications , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/immunology , Autoimmunity/immunology , Central Nervous System/pathology , Central Nervous System/physiopathology , Disease Progression , Female , Humans , Immunoglobulins, Intravenous/therapeutic use , Immunosuppressive Agents/therapeutic use , Magnetic Resonance Imaging , Middle Aged , Multiple Sclerosis/physiopathology , Myelin Sheath/immunology , Nerve Fibers, Myelinated/immunology , Nerve Fibers, Myelinated/pathology , Peripheral Nervous System/pathology , Peripheral Nervous System/physiopathology , Polyradiculoneuropathy, Chronic Inflammatory Demyelinating/physiopathology , Secondary Prevention , T-Lymphocytes/immunology , Treatment Outcome
9.
Int J Artif Organs ; 24(10): 743-51, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11817322

ABSTRACT

Skin flap survival is a significant problem in skin surgery; in particular, inadequate arterial or venous blood supply results in necrosis of the distalmost portion. The aim of this study was to evaluate the ability of Vascular Endothelial Growth Factor (VEGF) of modifying the morphological features of skin flaps. Bilateral epigastric skin flaps were raised in 16 Wistar male rats. The epigastric artery and vein of the left flaps were clamped and then injected with rhVEGF (8 rats) or saline (8 rats). The right flaps were not clamped and received rhVEGF or saline systemically. The rats were euthanized on the seventh day and flap skin samples collected. Tissue fragments were subject to immunohistochemical (rhVEGF, VEGFr, VIII factor, CD34 antibodies), ultrastructural and morphostructural investigations. The results showed that rhVEGF improved the condition of flaps and that systemic administration was effective in promoting the development of an adequate vascular network.


Subject(s)
Endothelial Growth Factors/administration & dosage , Graft Rejection/prevention & control , Lymphokines/administration & dosage , Skin Transplantation/pathology , Skin/pathology , Animals , Drug Administration Routes , Graft Rejection/pathology , Graft Survival , Male , Rats , Rats, Wistar , Recombinant Proteins/administration & dosage , Skin/ultrastructure , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
10.
Ann Hematol ; 80(12): 758-62, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11797120

ABSTRACT

Cerebral involvement is an unusual complication in multiple myeloma: herein four patients who presented myelomatous meningitis with multiple intraparenchymal lesions or a localized cerebral plasmacytoma are described. Two of these patients relapsed with meningeal involvement and a very limited disease outside the central nervous system after an initial complete remission obtained with induction chemotherapy. In the other two cases, the cerebral tumor appeared during first-line treatment. Cytological examination of the cerebrospinal fluid and magnetic resonance were essential for diagnosis. Different modalities of treatment were used, including intrathecal chemotherapy, cranial irradiation, and systemic chemotherapy with high-dose methotrexate and cytarabine, achieving improvement of neurological symptoms in three of four patients.


Subject(s)
Brain Neoplasms/complications , Meningitis/etiology , Multiple Myeloma/complications , Plasmacytoma/complications , Aged , Antineoplastic Agents/therapeutic use , Brain Neoplasms/cerebrospinal fluid , Brain Neoplasms/diagnosis , Brain Neoplasms/therapy , Cerebrospinal Fluid/cytology , Cerebrospinal Fluid Proteins/analysis , Combined Modality Therapy , Fatal Outcome , Female , Glucocorticoids/therapeutic use , Humans , Immunoglobulin Light Chains/analysis , Immunoglobulin kappa-Chains/analysis , Magnetic Resonance Imaging , Meningitis/cerebrospinal fluid , Meningitis/diagnosis , Meningitis/therapy , Middle Aged , Multiple Myeloma/cerebrospinal fluid , Multiple Myeloma/therapy , Plasmacytoma/cerebrospinal fluid , Plasmacytoma/diagnosis , Plasmacytoma/therapy , Prednisone/therapeutic use , Radiotherapy , Recurrence , Remission Induction
11.
Clin Neurophysiol ; 111(11): 2025-31, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11068238

ABSTRACT

OBJECTIVE: To use transcranial magnetic stimulation (TMS) to define motor cortical excitability in chronic fatigue syndrome (CFS) subjects during a repetitive, bilateral finger movement task. METHODS: A total of 14 CFS patients were tested and compared with 14 age-matched healthy control subjects. TMS of the motor cortex (5% above threshold) was used to elicit motor evoked potentials (MEPs). Subjects performed regular (3-4/s) repetitive bilateral opening-closing movements of the index finger onto the thumb. MEPs of the first dorsal interosseus (FDI) were measured before, immediately following exercise periods of 30, 60 and 90 s, and after 15 min of rest. RESULTS: Performance, defined by rate of movement, was significantly slower in CFS subjects (3.5/s) than in controls (4. 0/s) independent of the hand measured. The rate, however, was not significantly affected by the exercise duration for either group. The threshold of TMS to evoke MEPs from the FDI muscle was significantly higher in CFS than in control subjects, independent of the hemisphere tested. A transient post-exercise facilitation of MEP amplitudes immediately after the exercise periods was present in controls independent of the hemisphere tested, but was absent in CFS subjects. A delayed facilitation of MEPs after 15-30 min of rest was restricted to the non-dominant hemisphere in controls; delayed facilitation was absent in CFS subjects. CONCLUSIONS: Individuals with CFS do not show the normal fluctuations of motor cortical excitability that accompany and follow non-fatiguing repetitive bimanual finger movements.


Subject(s)
Fatigue Syndrome, Chronic/physiopathology , Magnetics , Motor Cortex/physiopathology , Adult , Evoked Potentials, Motor/physiology , Female , Fingers/physiopathology , Humans , Male , Movement/physiology
12.
Clin Neurophysiol ; 111 Suppl 2: S115-9, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10996564

ABSTRACT

The interactions between sleep and epilepsy are well known. A nodal point of the relationship between sleep and epilepsy is represented by pharmacological treatment. Sleep disturbances such as drowsiness are among the most frequent side effects of treatment with antiepileptic drugs, since they can deeply modify both sleep architecture and the sleep-wake cycle. Severe daytime somnolence affects patients' activities and it may facilitate the occurrence of seizures. These considerations underline the importance of antiepileptic drugs having anticonvulsant properties that do not negatively influence sleep and daytime somnolence. In this paper we review some relevant aspects of the effects of antiepileptic drugs on sleep.


Subject(s)
Anticonvulsants/pharmacology , Epilepsy/drug therapy , Sleep/drug effects , Anticonvulsants/therapeutic use , Epilepsy/physiopathology , Humans , Sleep/physiology
13.
Clin Neurophysiol ; 111(9): 1654-60, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10964079

ABSTRACT

OBJECTIVES: To define motor cortical excitability changes occurring at various times after non-fatiguing bimanual exercise of the index fingers. METHODS: Twenty healthy right-handed subjects were studied with transcranial magnetic stimulation (TMS) of the right non-dominant hemisphere. They performed regular (3-4/s) repetitive opening-closing bilateral movements of the index finger onto the thumb. Motor evoked potentials (MEPs) of the left first dorsal interosseus (FDI) and rate of the repetitive finger movements were determined (1) before exercise, (2) immediately following 3 exercise periods of 30, 60 and 90 s, and (3) over a subsequent 30 min rest period. RESULTS: Rate of movement did not show significant change during any of the exercise periods but did increase significantly when tested after 15 min of rest. MEPs immediately after 30 and 60 s of exercise were facilitated whereas MEPs after 90 s of exercise did not differ from baseline measures. MEP amplitudes were significantly increased after rest of approximately 15 min compared to the baseline MEPs. In contrast, motor potentials evoked by peripheral nerve stimulation were unchanged throughout the experimental test periods. CONCLUSIONS: Motor cortical excitability relating to an intrinsic finger muscle (FDI) was facilitated beginning 15 min after a brief period of non-forceful, repetitive activity of that muscle. This delayed facilitation of motor cortex after exercise may represent a form of short-term potentiation of motor cortical excitability.


Subject(s)
Fingers/physiology , Muscles/physiology , Adolescent , Adult , Evoked Potentials, Motor/physiology , Female , Humans , Magnetics , Male , Middle Aged , Peripheral Nerves/physiology , Time Factors
15.
Acta Neurol Scand ; 102(2): 81-6, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10949523

ABSTRACT

OBJECTIVES: The aim of our study was to evaluate possible changes in nocturnal sleep, daytime somnolence and cognitive functions induced by add-on therapy with lamotrigine (LTG). MATERIAL AND METHODS: Thirteen patients affected by seizures resistant to common antiepileptic drugs (AEDs) underwent nocturnal polysomnographic monitorings, daytime somnolence evaluations and a neuropsychological battery before and after 3 months of treatment with LTG. RESULTS: With LTG therapy we observed a significant increase in REM sleep and a significant reduction in the number of entries into REM and stage shifts. No significant correlation was observed between the decrease in nocturnal epileptiform activity and the increase in REM sleep. Other sleep parameters were unmodified. No significant changes were observed in daytime somnolence and in cognitive performances. CONCLUSION: LTG may produce positive effects on epileptic seizures and interictal abnormalities without interfering negatively on REM sleep, with improvement of sleep stability and without changes in daytime somnolence and neuropsychological performances. For these reasons it could be an important drug for improving epileptic patients' quality of life.


Subject(s)
Anticonvulsants/pharmacology , Cognition/drug effects , Epilepsies, Partial/drug therapy , Sleep Stages/drug effects , Triazines/pharmacology , Adolescent , Adult , Anticonvulsants/therapeutic use , Brain/physiopathology , Drug Resistance, Multiple , Drug Therapy, Combination , Epilepsies, Partial/physiopathology , Female , Humans , Lamotrigine , Male , Middle Aged , Polysomnography , Sleep, REM/drug effects , Treatment Outcome , Triazines/therapeutic use
16.
Neurology ; 54(5 Suppl 1): S25-32, 2000.
Article in English | MEDLINE | ID: mdl-10718681

ABSTRACT

Our objective was to determine, in three separate studies, the effects of controlled-release carbamazepine (CBZ-CR), lamotrigine (LTG), and gabapentin (GBP) on nocturnal sleep in epilepsy. Antiepileptic drugs (AEDs) control seizures and also modify hypnic structure. Despite widespread clinical use, their effects on sleep are not well known. PSG was performed in all three studies as follows: CBZ-CR: at baseline, after initial administration of CBZ-CR 400 mg, and after 1 month of CBZ-CR treatment (400 mg BID) in a sample of seven temporal lobe epileptic (TLE) patients. Results were compared with those of nine healthy volunteers; LTG: at baseline, after 3 months of stable treatment with LTG (300 mg/day); GBP: at baseline, after 3 months of stable treatment with GBP (1800 mg/day). Significant findings are as follows for each study. The acute administration of CBZ-CR increased number of stage shifts, reduced REM sleep, and increased REM sleep fragmentation. In the TLE group, these effects were almost completely reversed after chronic treatment. LTG increased REM sleep, reduced number of entries into REM sleep, decreased number of phase shifts, and decreased percentage of slow-wave sleep. GBP increased REM sleep percentage, increased mean duration of REM periods, reduced number of awakenings, and reduced stage 1 sleep percentage. We conclude that CBZ-CR disrupts REM sleep, but only during acute administration. LTG and GBP improve sleep stability while reducing seizures.


Subject(s)
Amines , Anticonvulsants/therapeutic use , Circadian Rhythm/physiology , Cyclohexanecarboxylic Acids , Epilepsy/drug therapy , Epilepsy/physiopathology , Sleep/drug effects , Sleep/physiology , gamma-Aminobutyric Acid , Acetates/therapeutic use , Adult , Carbamazepine/therapeutic use , Female , Gabapentin , Humans , Lamotrigine , Male , Middle Aged , Triazines/therapeutic use
17.
Neurology ; 54(1): 58-64, 2000 Jan 11.
Article in English | MEDLINE | ID: mdl-10636126

ABSTRACT

OBJECTIVE: To reverse the profile of abnormal intracortical excitability in patients with ALS by administering drugs that promote GABAergic transmission. BACKGROUND: Transcranial magnetic stimulation (TMS) has revealed abnormalities of cortical inhibition in ALS, a reduction of the silent period, and the absence of intracortical inhibition normally occurring in response to paired TMS. Impaired inhibitory transmission could play a role in the physiopathology of this illness. METHODS: Using paired TMS with conditioning stimuli from 1-to-6-msec-interstimulus intervals, we investigated 16 patients with ALS. The protocol included: (1) the "drug-free" profile of paired TMS; (2) paired TMS 30 minutes after the intake of diazepam (3.5 mg); (3) paired TMS after 3 weeks' treatment with gabapentin (GBP) (600 mg/day) or riluzole (50 mg/twice a day). RESULTS: Intracortical inhibition is lost in patients with ALS, and this abnormal profile is reversed by diazepam or sustained treatment with GBP. We also noted that motor-evoked potential amplitudes to single stimuli increased (p<0.01) after diazepam and GBP. CONCLUSIONS: The demonstration of pharmacologic reversal of hyperexcitability in patients with ALS makes a potentially significant contribution toward understanding the pathophysiology of a disease that has so far eluded an effective cure.


Subject(s)
Amines , Amyotrophic Lateral Sclerosis/drug therapy , Amyotrophic Lateral Sclerosis/physiopathology , Cerebral Cortex/drug effects , Cerebral Cortex/physiopathology , Cyclohexanecarboxylic Acids , gamma-Aminobutyric Acid , Acetates/therapeutic use , Diazepam/therapeutic use , Drug Therapy, Combination , Evoked Potentials, Motor , Female , GABA Agonists/therapeutic use , GABA Modulators/therapeutic use , Gabapentin , Humans , Magnetics , Male , Middle Aged , Neural Inhibition/drug effects , Neuroprotective Agents/therapeutic use , Physical Stimulation/methods , Riluzole/therapeutic use , Synaptic Transmission/drug effects , Treatment Outcome
18.
J Neurol Sci ; 169(1-2): 98-107, 1999 Oct 31.
Article in English | MEDLINE | ID: mdl-10540016

ABSTRACT

A population of 31 patients with sporadic amyotrophic lateral sclerosis (ALS) was selected for a prospective open study based on treatment with riluzole. A neurophysiological evaluation was performed by means of single and paired transcranial magnetic stimulation (TMS). The examined parameters, excitability threshold, motor evoked potential (MEP) duration, silent period (SP) duration and time course of intracortical inhibition to paired TMS after 6 months treatment, were matched against those recorded from the patients themselves before the beginning of treatment and from 20 (single TMS) or 10 (paired TMS) age-matched control subjects. Normal behaviour of the SP in response to increasing TMS was found in the treated patients; they showed a significant linear correlation between these two parameters (r=0.96) comparable to that calculated for controls (r=0.98), and significantly different with respect to drug-free patients (r=0.8, P=0.014). A significant reduced size of the 'conditioned' MEPs to paired stimulation was documented in the treated patients compared with the untreated patients (P=0.002). Our neurophysiological contribution to the assessment of the effect of riluzole on the motor cortical inhibitory property in ALS may be considered a setting for controlled trials in extended patient series, even in a pre-clinical phase.


Subject(s)
Amyotrophic Lateral Sclerosis , Evoked Potentials, Motor/drug effects , Excitatory Amino Acid Antagonists/therapeutic use , Riluzole/therapeutic use , Adult , Aged , Analysis of Variance , Electric Stimulation , Electromagnetic Phenomena , Female , Humans , Male , Middle Aged , Prospective Studies
19.
Brain Dev ; 21(8): 548-53, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10598057

ABSTRACT

We compared sleep parameters in mentally retarded infantile autism (MRIA) and mentally retarded Down's syndrome (MRDS) by means of polysomnography, evaluating traditional analysis with particular attention to the phasic components in each disorder. Data were compared with those obtained in normal subjects matched for age and sex. Mental age, Intellectual Quotient and the Childhood Autism Rating Scale were performed to obtain an estimation of the neuropsychological deficit. Abnormalities of phasic components of sleep and the presence of REM sleep components into non-REM sleep were observed in both MRIA and MRDS even if in different ways. In fact, MRDS subjects presented a reduction of REM sleep percentage and R index (number of high frequency REMs against number of low frequency REMs) and this was positively correlated to a low IQ. Unlike MRDS subjects, MRIA subjects did not show any parallelism between intellectual abilities and REM sleep deficit. In addition, the presence of undifferentiated sleep in autistic subjects implies a maturational deficit that is still present in adulthood. Finally, a high R index in MRIA was observed. This finding, which is not present in MRDS, could represent an estimation of the disorganized arrival of information caused by a dyscontrol or a reduction of inhibitor pathway. With reference to sleep mechanisms, our results suggest that the cognitive deficit in MRIA may differ from that of MRDS subjects. A maturational deficit of CNS with a dysfunction of brainstem monoaminergic neurons could represent the underlying mechanism.


Subject(s)
Autistic Disorder/complications , Down Syndrome/complications , Intellectual Disability/complications , Sleep Wake Disorders/complications , Sleep Wake Disorders/physiopathology , Adolescent , Adult , Child , Electroencephalography , Female , Humans , Male , Sleep/physiology
20.
J Infect ; 38(3): 191-2, 1999 May.
Article in English | MEDLINE | ID: mdl-10424801

ABSTRACT

We report the case of a patient with a massive crushing trauma of the right foot who developed a local infection due to Absidia corymbifera. Systemic and local antifungal therapy with ketoconazole associated with hyperbaric oxygen therapy (HBO) yielded a rapid clinical and microbiological resolution. Controlled clinical studies are warranted to further elucidate the potential utility of HBO/antifungal combination therapy.


Subject(s)
Absidia/isolation & purification , Foot Injuries/complications , Mucormycosis/etiology , Absidia/drug effects , Aged , Antifungal Agents/therapeutic use , Combined Modality Therapy , Humans , Hyperbaric Oxygenation , Male , Microbial Sensitivity Tests , Mucormycosis/microbiology , Mucormycosis/therapy , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...